MYRX
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2013 Q4 | -0.01 | $0 | -$304,000 |
| 2013 Q3 | -0.11 | $0 | -$2M |
| 2012 Q2 | -0.18 | $0 | -$5M |
| 2012 Q1 | -0.13 | $0 | -$5M |
| 2012 Q4 | -0.01 | $0 | -$7M |
| 2012 Q3 | -0.40 | $0 | -$7M |
| 2011 Q2 | -0.29 | $0 | -$7M |
| 2011 Q1 | -0.33 | $0 | -$7M |